Betnovate
$ 40,00 – $ 55,00Price range: $ 40,00 through $ 55,00
Biaxin
$ 107,00 – $ 427,00Price range: $ 107,00 through $ 427,00
Betoptic
$ 40,00 – $ 98,00Price range: $ 40,00 through $ 98,00
Betoptic is a specialized ophthalmic solution designed to effectively manage elevated intraocular pressure. As a selective beta-1 blocker, this medication works by reducing the production of fluid within the eye. It is primarily indicated for individuals diagnosed with chronic open-angle glaucoma or ocular hypertension. By maintaining healthy pressure levels, Betoptic helps protect the optic nerve and preserve long-term visual health. The sterile drops provide targeted action, offering a reliable option for daily ocular care and maintenance.
Active substance: Betaxolol
SKU:
Betoptic
Category: Eye Care
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Betoptic belongs to a class of topical ophthalmic medications known as cardioselective beta-adrenergic receptor blocking agents. It contains betaxolol hydrochloride, a specialized active compound formulated for administration directly onto the ocular surface to assist in managing intraocular pressure. As a prescription ophthalmic solution, its distribution and usage are regulated under applicable federal and state laws in the United States.
The primary clinical function of Betoptic is to reduce elevated pressure within the eye, which serves as a major modifiable risk factor for progressive visual field loss and optic nerve damage. By decreasing aqueous humor formation in the anterior segment of the eye, it helps maintain ocular health in individuals diagnosed with specific ophthalmic conditions. Proper instillation technique and compliance with medical supervision are required to maximize therapeutic benefits while minimizing systemic exposure.
Pharmacological Profile and Clinical Application
Basic Information Overview
| Property | Specification |
|---|---|
| Active ingredient (INN) | Betaxolol hydrochloride |
| Therapeutic class | Cardioselective beta-1 adrenergic antagonist |
| Dosage form | Ophthalmic solution |
| Route of administration | Ophthalmic (topical eye drop) |
| Primary purpose | Reduction of elevated intraocular pressure |
| Prescription status | Rx only (Prescription required) |
Main uses
Betoptic is indicated for the lower of intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension. It may be prescribed as monotherapy or in conjunction with other intraocular pressure-lowering agents when target pressure goals are not achieved with a single agent. Ocular hypertension is characterized by intraocular pressure exceeding normal limits without detectable optic nerve damage or visual field defects. Chronic open-angle glaucoma involves progressive optic neuropathy associated with elevated or normal intraocular pressure levels. The medication is intended exclusively for ophthalmic use under ongoing medical supervision.
How the drug works
Betaxolol hydrochloride functions as a cardioselective beta-1 adrenergic receptor blocking agent. When applied topically to the eye, it acts on the ciliary body to inhibit the secretion of aqueous humor, thereby lowering internal ocular pressure. Unlike non-selective beta-blockers, betaxolol demonstrates a higher affinity for beta-1 adrenergic receptors than for beta-2 receptors. This selectivity provides a lower propensity to induce pulmonary smooth muscle constriction in vulnerable individuals, though systemic absorption remains possible following ocular administration.
What happens in the body
Following topical instillation of Betoptic, the onset of action typically occurs within 30 minutes, with peak pressure-lowering effects observed approximately two hours post-administration. The therapeutic response is maintained for up to 12 hours. A portion of the instilled drop drains through the nasolacrimal duct into the systemic circulation, where betaxolol undergoes hepatic metabolism before being eliminated primarily by the kidneys. Ocular tissue distribution concentrates the active substance in the anterior segment structures responsible for aqueous humor dynamics.
Dosing schedule
The standard recommended dosage of Betoptic ophthalmic solution is one drop in the affected eye (or eyes) twice daily, spaced approximately 12 hours apart. The exact dosing regimen is determined individually by the prescribing physician based on initial intraocular pressure measurements and clinical response. Patients must adhere strictly to the designated schedule to maintain steady intraocular pressure control throughout the 24-hour period. If target pressure is not adequately controlled, the prescribing professional may re-evaluate the therapeutic strategy.
Safety Guidelines and Operational Considerations
Adverse reactions
Local ocular reactions are the most frequently reported side effects associated with Betoptic. Patients may experience transient ocular discomfort, stinging, burning, increased tearing, or a foreign body sensation upon instillation. Additional ocular adverse events include corneal sensitivity reduction, blurred vision, punctate keratitis, photophobia, and conjunctival redness. Although systemic absorption is minimal compared to oral beta-blockers, systemic side effects can occur, including sinus bradycardia, hypotension, headache, dizziness, insomnia, and mild respiratory symptoms such as bronchospasm in hypersensitive individuals.
Important precautions
Betoptic is contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, or overt cardiac failure. Caregivers and prescribers must evaluate underlying cardiovascular and respiratory health prior to initiating treatment. Although betaxolol is beta-1 selective, caution is warranted when administering the drug to individuals with severe chronic obstructive pulmonary disease (COPD) or asthma. Regular monitoring of intraocular pressure and visual field status is required throughout the duration of therapy.
Compatibility with other medicines
Concomitant administration of Betoptic with systemic beta-adrenergic blocking agents may result in additive effects on both intraocular pressure and systemic cardiovascular parameters. Simultaneous use with catecholamine-depleting agents, such as reserpine, warrants close observation due to the potential for cumulative hypotension or severe bradycardia. Calcium channel antagonists or digitalis glycosides taken concurrently may increase the risk of cardiac conduction abnormalities. Patients must inform their prescriber of all systemic and topical prescription or over-the-counter medications currently in use.
Special populations
The safety and efficacy of Betoptic in pediatric patients have not been established; use in children requires specialized ophthalmic consultation. Pregnant women should use Betoptic only if the potential benefit justifies the risk to the fetus, as adequate clinical studies in pregnant populations are limited. Betaxolol is excreted in human milk following systemic administration; caution should be exercised when prescribing to nursing mothers. Clinical evaluations in geriatric patients demonstrate similar efficacy and safety profiles compared to younger adult cohorts, though heightened sensitivity to systemic beta-blockade remains possible.
If you skip a dose
If a dose of Betoptic is missed, it should be administered as soon as remembered. If the time of recollection is close to the next scheduled administration, the missed dose should be omitted, and the regular schedule resumed. Double dosing or instilling extra drops to make up for a missed application must be avoided, as excessive dosing increases the likelihood of systemic absorption and localized ocular irritation.
Practical tips
Contact lenses must be removed prior to the instillation of Betoptic, as the solution contains preservatives such as benzalkonium chloride, which can be absorbed by soft lenses. Lenses may be reinserted 15 minutes after administration. To maintain sterility, the tip of the dropper bottle must not touch the eye, surrounding eyelids, fingers, or any other surface. Applying gentle digital pressure to the inner corner of the eye (nasolacrimal occlusion) for one to two minutes after instillation reduces systemic absorption through the nasal mucosa.
Storage and expiration
Betoptic ophthalmic solution should be stored at controlled room temperature between 59°F and 77°F (15°C to 25°C). The container must be kept tightly closed when not in use and protected from direct sunlight and excessive freezing temperatures. The bottle must be discarded after the expiration date printed on the primary package. Keep out of reach of children and domestic pets.
Common Questions
What makes cardioselective eye drops different from non-selective options?
Cardioselective agents like betaxolol primarily target beta-1 adrenergic receptors located predominantly in the heart and ciliary body, rather than beta-2 receptors in the lungs. This selectivity lowers the potential risk of causing airway constriction compared to non-selective beta-blockers. However, systemic selectivity is relative, and cautious monitoring remains necessary in patients with respiratory conditions.
Can Betoptic affect heart rate or blood pressure?
Because topically applied eye drops enter the systemic circulation via nasolacrimal drainage, systemic beta-blockade is possible. In susceptible patients, this can manifest as a slight decrease in heart rate or mild lowering of blood pressure. Performing nasolacrimal occlusion immediately after instillation helps minimize the systemic absorption of the active drug.
How long should I wait before putting in contact lenses after using Betoptic?
Patients should wait at least 15 minutes after instilling Betoptic before reinserting soft contact lenses. The formulation contains benzalkonium chloride, a preservative that can adhere to lens materials and potentially cause corneal discomfort. Always consult your eye care specialist regarding contact lens wear during glaucoma therapy.
What should I do if I am using more than one eye drop medication?
When multiple topical ophthalmic medications are prescribed, instillation of each medication should be separated by an interval of at least 5 to 10 minutes. Spacing out applications prevents the second drop from washing away the first drop before it can be absorbed by the ocular tissue.
Is it acceptable to stop using Betoptic if my eye pressure reaches a normal level?
Betoptic should not be discontinued abruptly without direct instruction from an eye care provider. Glaucoma and ocular hypertension are chronic conditions, and normal pressure readings indicate that the medication is actively working. Stopping treatment can lead to a rebound increase in intraocular pressure and risk further nerve damage.
In accordance with FDA requirements.
This text is for informational purposes only and does not constitute individual medical advice.
Additional information
| Dosage |
5ml |
|---|---|
| Package |
3 bottles ,4 bottles ,5 bottles ,6 bottles ,7 bottles ,8 bottles ,9 bottles ,10 bottles |
| Ενεργός Ουσία |
Related products
Bimat
$ 60,00 – $ 330,00Price range: $ 60,00 through $ 330,00
Active substance: Bimatoprost
More Details
This product has multiple variants. The options may be chosen on the product page
Ciloxan Ophthalmic Solution
$ 50,00 – $ 63,00Price range: $ 50,00 through $ 63,00
Active substance: Ciprofloxacin hydrochloride
More Details
This product has multiple variants. The options may be chosen on the product page
Cyclogyl
$ 32,00
Active substance: Cyclopentolate ophthalmic
More Details
This product has multiple variants. The options may be chosen on the product page
Cyclomune Eye Drops
$ 13,00 – $ 69,00Price range: $ 13,00 through $ 69,00
Active substance: Cyclosporine
More Details
This product has multiple variants. The options may be chosen on the product page
Diamox
$ 60,00 – $ 144,00Price range: $ 60,00 through $ 144,00
Active substance: Acetazolamide
More Details
This product has multiple variants. The options may be chosen on the product page
Lumigan
$ 53,00 – $ 490,00Price range: $ 53,00 through $ 490,00
Active substance: Bimatoprost
More Details
This product has multiple variants. The options may be chosen on the product page
Norwayz
$ 49,00 – $ 69,00Price range: $ 49,00 through $ 69,00
Active substance: Idebenone
More Details
This product has multiple variants. The options may be chosen on the product page
Toba Eye Drops
$ 11,00 – $ 31,00Price range: $ 11,00 through $ 31,00
Active substance: Tobramycin
More Details
This product has multiple variants. The options may be chosen on the product page
